MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Towards a Machine Learning Based Classification System for Hyperkinetic Movement Disorders: Generating a Neurophysiological Feature Set

    E. V.D. Brandhof, S. V.D. Veen, G. Russo, I. Tuitert, J. Dalenberg, M. V.D. Stouwe, J. Elting, M. Biehl, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: Generating a set of significant neurophysiological features to build a machine learning based diagnostic system for hyperkinetic movement disorders. Background: Hyperkinetic movement disorders cause…
  • 2022 International Congress

    Longitudinal study of clinical and neurophysiological features of essential tremor

    L. Angelini, A. de Biase, G. Paparella, A. Di Vita, M. Panfili, A. Maraone, R. Margiotta, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: This study investigates how motor and non-motor manifestations of essential tremor (ET) progress over time. Background: ET is a common and heterogeneous movement disorder…
  • 2022 International Congress

    Clinical,imaging and genetic correlations in a Neuronal Brain Iron accumulation cohort from India

    K P. Divya, A. Cherian, M. Chandarana, S. Krishnan (Thiruvananthapuram, India)

    Objective: To correlate, clinical and magnetic resonance imaging (MRI) characteristics, of patients with neurodegeneration with brain iron accumula­tion (NBIA), with genetics and establish genotype-phenotype correlations…
  • 2022 International Congress

    High preoperative gait variability is a prognostic predictor of gait and balance in Parkinson disease patients with deep brain stimulation

    JH. Shin, R. Yu, CY. Lee, KA. Woo, HJ. Chang, HJ. Kim, JH. Lee, B. Jeon (Seoul, Republic of Korea)

    Objective: To elucidate the objective biomarker for long-term outcome of STN DBS in PD patients, we investigated the value of pre-operative quantitative gait parameters for…
  • 2022 International Congress

    Resistance training in patients with Parkinson’s disease: a systematic review and meta-analysis

    R. Gollan, M. Ernst, E. Lieker, J. Caro-Valenzuela, I. Monsef, A. Dresen, M. Roheger, N. Skoetz, E. Kalbe, AK. Folkerts (Cologne, Germany)

    Objective: To analyze the effects of resistance training (RT) on motor- and non-motor outcomes in patients with Parkinson's disease (PD) compared to passive and physically…
  • 2022 International Congress

    The results of DBS in patients with Parkinson’s disease for 10 years in Belarus

    A. Buniak, V. Alexeyevets, S. Likhachev (Minsk, Belarus)

    Objective: To study the efficiency and SE of DBS in PD patients in Republican Research and Clinical Center of Neurology and Neurosurgery in Belarus for…
  • 2022 International Congress

    GDNF Gene Therapy for Parkinson’s Disease (PD): Preliminary Safety and Clinical Findings from a Phase Ib Study

    A. van Laar, C. Christine, A. Merola, N. Phielipp, B. Elder, P. Larson, N. Stoicea, W. San Sebastian, M. Fiandaca, A. Kells, K. Bankiewicz (Research Triangle Park, USA)

    Objective: Assess the safety and tolerability of intraputaminal AAV2-GDNF in mild to moderate PD Background: Glial cell line-derived neurotrophic factor (GDNF) is critical for dopaminergic…
  • 2022 International Congress

    Nocturnal attacks of abnormal sleep behaviors and abnormal movements induced by insulin: A case report

    S. El-Jaafary (Cairo, Egypt)

    Objective: To report a case of abnormal sleep behavior associated with hypoglycemia induced by insulin. Background: Hypoglycemia is a serious condition that can be manifested…
  • 2022 International Congress

    Levodopa-carbidopa intestinal gel infusion and long-term tolerability in Parkinson’s: multicentre, international 13-year follow-up data

    V. Leta, L. Batzu, L. Williams, S. Waller, F. Garri, K. Rukavina, M. Parry, S. Jones, J. Griffith, N. Jeyakumar, M. Scharfenort, P. Odin, V. Metta, G. Chung-Faye, P. Dubois, T. Marshall, A. Zecchinelli, F. Del Sorbo, V. Viljaharju, E. Pekkonen, A. Antonini, V. Fung, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To evaluate the long-term range and nature of Levodopa-carbidopa intestinal gel (LCIG) infusion-related complications in people with Parkinson’s (PwP). Background: LCIG infusion is an…
  • 2022 International Congress

    Automatic Speech Recognition for speech therapy in a Parkinson’s disease patient

    A. Nuzzi (Bari, Italy)

    Objective: The aim of the present study was to examine the Automatic Speech Recognition (ASR) technology as a useful approach to enhance the speech intelligibility…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley